Thomas Clozel

Contributor

Thomas Clozel, M.D., is co-founder and CEO of Owkin, former assistant professor of clinical onco-hematology at Hôpital Henri-Mondor in Paris, and former member of the Melnick Lab at Weill Cornell Medicine in New York.

Biotech & Health

How AI is helping to make breast cancer history

Thomas Clozel

7:05 am PDT • October 17, 2021

With AI helping to diagnose patients earlier and enabling the rapid development of treatments, it is possible that in a few decades, we may no longer have the need for…